Results 91 to 100 of about 30,955 (215)

Interventions for submacular haemorrhage: A systematic review and network meta‐analysis of controversies—On behalf of the Spanish Vitreo‐Retinal Society (SERV)

Acta Ophthalmologica, Volume 104, Issue 2, Page 139-163, March 2026.
Abstract Purpose This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage (SMH), highlighting the controversies and differences in clinical practice. Method A systematic review was conducted following the PRISMA guidelines.
Salvador Pastor‐Idoate, Pablo Redruello‐Guerrero, Laura de Juan Hernández, Gregorio Benites‐Narcizo, Mario Rivera‐Izquierdo, José García‐Arumí, José Carlos Pastor Jimeno   +6 more
wiley   +1 more source

Intravitreal bevacizumab for neovascular age-related macular degeneration

Philippine Journal of Ophthalmology, 2009
Objectives: Anti-vascular endothelial growth factor (anti-VEGF) drugs delivered intravitreally have been proven effective and safe for the treatment of patients diagnosed with neovascular age-related macular degeneration (ARMD).
Junn R. Pajarillo, MD, Harvey S. Uy,MD, Milagros H. Arroyo MD, MPH   +2 more
doaj  

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration [PDF]

, 2017
Background: It has been proposed that antioxidants may prevent cellular damage in the retina by reacting with free radicals that are produced in the process of light absorption.
Age-Related Eye Disease Study 2 Research Group, Age-Related Eye Disease Study Research Group, Age-Related Eye Disease Study Research Group, Akuffo, Akuffo, Andreatta, Angelo, Anonymous, Arnold, Bahrami, Barakat, Bartlett, Bartlett, Beatty, Beatty, Benzie, Berrow, Bjelakovic, Bonds, Bone, Broadhead, Bunce, Buschini, Cangemi, Carneiro, Chew, Chew, Chew, Chew, Chew, Chew, Christen, Christen, Christen, Christen, Clemons, Connolly, Cumurcu, Dawczynski, Dawczynski, Downie, Early Treatment Diabetic Retinopathy Study Research Group, Evans, Evans, Evans, Falsini, Franciose, Garrett, Garrett, Glanville, Goodrow, Grover, Hanus, Holz, Huang, Huang, Huang, Huang, Hubbard, Johnson, Kaiser, Kamburoglu, Khachik, Klein, Kolber, Kopsell, Kvansakul, Lai, Landrum, Lim, Liu, Lonn, Ma, Ma, Manikandan, Meagher, Moeller, Moriarty-Craige, Murray, Neelam, Newsome, Newsome, Nolan, Nolan, Nolan, Nussenblatt, Omenn, Owsley, Piermarocchi, Prasad, Richer, Richer, Richer, Richer, Robman, Rodriguez-Carmona, Rosenthal, Rudnicka, Sabour-Pickett, Sacconi, Sasamoto, Scalinci, Schalch, Schmetterer, Schmidl, Scorolli, Souied, Stur, Taylor, The, The Age-Related Eye Disease Study 2 (AREDS2) Research Group, The Age-Related Eye Disease Study Research Group, Tian, Tikellis, Told, Told, Trieschmann, Vannas, Wang, Wang, Weigert, Wenzel, Wolf-Schnurrbusch, Wong, Zampatti, Zeimer, Zhao   +126 more
core   +3 more sources

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Missed Hospital Appointments of Patients Receiving Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration [PDF]

, 2015
INTRODUCTION: The aim of this study was to investigate the frequency and duration of missed hospital appointments (MHAs) in a consecutive cohort of patients treated with ranibizumab for neovascular age-related macular degeneration (nAMD) and to assess ...
Aachal Kotecha, Angela Rees, Eleni Nikita, Maria Pefkianaki, Michael Karampelas, Navdeep Gill, Praveen J. Patel, Robin Hamilton   +7 more
core   +1 more source

Irigenin Modulates BL‐Induced Pyroptosis in Retinal Pigment Epithelial Cells Through p38 MAPK and NFκB Pathways

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 2, February 2026.
Irigenin alleviates blue light‐induced RPE cell damage by inhibiting NLRP3 inflammasome and p38/NF‐κB signalling, showing potential for AMD prevention. ABSTRACT Age‐related macular degeneration (AMD), a primary cause of vision loss among older adults, is strongly associated with inflammatory processes.
I‐Li Su, Kun‐Lin Yeh, Chien‐Ying Lee, Sheng‐Chien Lin, Chen‐Yu Chiang, Chun‐Jung Chen, Wen‐Ying Chen, Ching‐Chi Tseng, Yin‐Che Lu, Yu‐Hsiang Kuan   +9 more
wiley   +1 more source

Intravitreal injections: A brief note

Kerala Journal of Ophthalmology, 2018
The delivery of medications directly into the vitreous cavity through an injection or implant has become a commonplace in ophthalmology. Common diseases treated by intravitreal injections include neovascular age-related macular degeneration, clinically ...
Anu Joseph
doaj   +1 more source

Progress in RNA‐Targeted Therapeutics for Human Diseases

MedComm, Volume 7, Issue 2, February 2026.
RNA‐targeted therapies are revolutionizing molecular medicine by transitioning from a “protein‐centric” focus to an “RNA‐regulatory network” approach. Leveraging RNA's diverse roles in gene regulation, signaling, and epigenetic modifications, advanced platforms such as ASOs, siRNA, miRNA, mRNA, aptamers, shRNA, and CRISPR/Cas systems are enabling ...
Wangzheqi Zhang, Aimin Jiang, Bin‐Kui Jia, Yuming Jin, Yinghu Chen, Zhaoyu Li, Yan Liao, Haoling Zhang, Zhiheng Lin, Xiao Fang, Linhui Wang   +10 more
wiley   +1 more source

Real World Data Comparison of Standard Care vs SDM Laser Vision Protection Therapy for Prevention of Neovascular AMD

Clinical Ophthalmology, 2022
Jeffrey K Luttrull,1 Gerry Gray2 1Ventura County Retina Vitreous Medical Group, Ventura, CA, USA; 2Regulatory Pathways, Inc, Laguna Beach, CA, USACorrespondence: Jeffrey K Luttrull, Ventura County Retina Vitreous Medical Group, 3160 Telegraph Road, Suite
Luttrull JK, Gray G
doaj  

MSC‐Derived Exosomal lnc‐AGT‐3: A Novel Anti‐Angiogenic Target in Age‐Related Macular Degeneration Through p53 Signaling Pathway

Aging Cell, Volume 25, Issue 2, February 2026.
MSC‐derived exosomes deliver lnc‐AGT‐3 to vascular endothelial cells, where it binds hnRNP K in the nucleus. This interaction inhibits p53 ubiquitination, enhancing p53 stabilization and transcriptional activation of anti‐angiogenic targets TSP1. Consequently, p53‐mediated signaling is potentiated, effectively suppressing choroidal neovascularization ...
Lingjie Kong, Xiaoyan Han, Siyi Qi, Duo Li, Jingyue Zhang, Linyu Zhang, Shujie Zhang, Qin Jiang, Biao Yan, Chen Zhao   +9 more
wiley   +1 more source